Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ABT – Abbott Laboratories

Abbott Laboratories
ABT
$131.63
Name : Abbott Laboratories
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $228,288,544,768.00
EPSttm : 7.63
finviz dynamic chart for ABT
Abbott Laboratories
$131.63
0.23%
$0.3

Float Short %

1.27

Margin Of Safety %

-2

Put/Call OI Ratio

0.84

EPS Next Q Diff

-0.1

EPS Last/This Y

-2.52

EPS This/Next Y

0.55

Price

131.67

Target Price

138.14

Analyst Recom

1.83

Performance Q

16.37

Relative Volume

0.9

Beta

0.74

Ticker: ABT




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-03-05ABT137.680.760.85169543
2025-03-06ABT135.070.771.10172134
2025-03-07ABT137.130.790.11176429
2025-03-10ABT137.370.810.46169745
2025-03-11ABT132.650.800.60174877
2025-03-12ABT130.280.811.40177929
2025-03-13ABT129.870.811.37179809
2025-03-14ABT126.650.800.66180209
2025-03-17ABT127.630.820.49179993
2025-03-18ABT126.380.810.78181600
2025-03-19ABT127.460.810.76188200
2025-03-20ABT126.770.811.81189922
2025-03-21ABT126.310.801.31191993
2025-03-24ABT127.190.810.59173628
2025-03-25ABT125.610.810.20175274
2025-03-26ABT126.640.760.17186911
2025-03-27ABT131.380.750.35190199
2025-03-28ABT130.820.780.66195607
2025-03-31ABT132.670.810.74190338
2025-04-01ABT131.670.810.85191927
2025-04-02ABT131.910.831.32194275
2025-04-03ABT131.670.840.35197759
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-03-05ABT137.708.61744.95.15
2025-03-06ABT135.098.71564.95.15
2025-03-07ABT137.108.71872.15.15
2025-03-10ABT137.368.71751.55.15
2025-03-11ABT132.658.71426.65.15
2025-03-12ABT130.278.71574.65.15
2025-03-13ABT129.868.71707.95.15
2025-03-14ABT126.718.71516.05.15
2025-03-17ABT127.648.71803.25.15
2025-03-18ABT126.308.71642.35.15
2025-03-19ABT127.428.71817.05.15
2025-03-20ABT126.788.71691.75.15
2025-03-21ABT126.368.71707.15.15
2025-03-24ABT127.218.71799.15.15
2025-03-25ABT125.608.71622.85.15
2025-03-26ABT126.618.71809.55.15
2025-03-27ABT131.348.62073.95.15
2025-03-28ABT130.828.61700.55.15
2025-03-31ABT132.658.61863.35.15
2025-04-01ABT131.698.71671.65.15
2025-04-02ABT131.938.71753.55.15
2025-04-03ABT131.678.71719.25.15
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-03-05ABT-6.482.841.30
2025-03-06ABT-6.482.841.30
2025-03-07ABT-6.482.841.30
2025-03-10ABT-7.163.271.30
2025-03-11ABT-7.163.271.30
2025-03-12ABT-7.163.271.33
2025-03-13ABT-7.163.271.33
2025-03-14ABT-6.103.271.33
2025-03-17ABT-6.103.281.33
2025-03-18ABT-6.103.281.33
2025-03-19ABT-6.103.281.33
2025-03-20ABT-6.103.281.33
2025-03-21ABT-6.103.281.33
2025-03-24ABT-6.103.251.33
2025-03-25ABT-6.103.251.33
2025-03-26ABT-6.103.251.27
2025-03-27ABT-6.103.251.27
2025-03-28ABT-6.103.251.27
2025-03-31ABT-6.102.631.27
2025-04-01ABT-6.102.631.27
2025-04-02ABT-6.102.631.27
2025-04-03ABT-6.102.631.27
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

1.34

Avg. EPS Est. Current Quarter

1.07

Avg. EPS Est. Next Quarter

1.24

Insider Transactions

-6.1

Institutional Transactions

2.63

Beta

0.74

Average Sales Estimate Current Quarter

10389

Average Sales Estimate Next Quarter

10954

Fair Value

129.2

Quality Score

98

Growth Score

85

Sentiment Score

98

Actual DrawDown %

7.7

Max Drawdown 5-Year %

-33.9

Target Price

138.14

P/E

17.18

Forward P/E

23.07

PEG

1.62

P/S

5.44

P/B

4.78

P/Free Cash Flow

35.95

EPS

7.66

Average EPS Est. Cur. Y​

5.15

EPS Next Y. (Est.)

5.7

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

31.83

Relative Volume

0.9

Return on Equity vs Sector %

8.3

Return on Equity vs Industry %

10.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

1719.2
Abbott Laboratories
Sector: Healthcare
Industry: Medical Devices
Employees: 114000
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company provides pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
stock quote shares ABT – Abbott Laboratories Stock Price stock today
news today ABT – Abbott Laboratories stock forecast ,stock prediction 2023 2024 2025
marketwatch ABT – Abbott Laboratories yahoo finance google finance
stock history ABT – Abbott Laboratories invest stock market
stock prices ABT premarket after hours
ticker ABT fair value insiders trading